Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
KILITCH Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Moderate ROE but improving trend
Moderate operating margin but improving trend
Strong revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Negative
High and increasing Debt to Equity
Low dividend yield
Neutral
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.411801.
Snapshot
See detailed analysis
KILITCH Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
KILITCH Bulk, Block & Insider Trades
KILITCH Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Rights issue(2 new shares @ 357 INR for 23 existing shares)"Rights ISIN INE729D20010 CINS Y4775M109 SEDOL BNZHSJ1." Ex-date: 15th Jul 2025 Announced on: 2nd Jul 2025
Rights issue(2 new shares @ 10 INR for 3 existing shares)Cum price is INR 16.75 Ex-date: 11th Sep 1995 Announced on: 1st Sep 1995
Company Profile
Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers prod... Read More
Key personnel
Mr. Sunil Sureshji Jain
Chief Financial Officer
Ms. Pushpa Nyoupane
Chief Compliance Officer, Company Secretary
Mr. Mukund Prataprai MehtaD
Managing Director, Executive Director
Mrs. Mira Bhavin Mehta
Managing Director
Mr. Bhavin Mukund MehtaD
Wholetime Director
Mr. Dipen Jayantilal JainD
Additional Non-Executive Independent Director
Prof. Murti Vasudev KrishnaD
Non-Executive Independent Director
Mr. Venkita Subramanian RajanD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Kilitch Drugs (India) Ltd.?
The current share price of Kilitch Drugs (India) Ltd. is ₹ 334.88 as of 09 Jan 2026.
What is the PE ratio of Kilitch Drugs (India) Ltd.?
The Price-to-Earnings (PE) ratio of Kilitch Drugs (India) Ltd. is 21.05 as of the latest financial data.
What is the ROE and ROCE of Kilitch Drugs (India) Ltd.?
Kilitch Drugs (India) Ltd. has a Return on Equity (ROE) of 12.22% and a Return on Capital Employed (ROCE) of 1.59% as per the latest financial reports.
What is the market cap of Kilitch Drugs (India) Ltd.?
The market capitalization of Kilitch Drugs (India) Ltd. stands at ₹ 585.40 Cr.
What is the dividend yield of Kilitch Drugs (India) Ltd.?
The dividend yield of Kilitch Drugs (India) Ltd. is 0.00% based on the current market price.
What is the RSI of Kilitch Drugs (India) Ltd.?
The Relative Strength Index (RSI) of Kilitch Drugs (India) Ltd. is 40.16.
What is the FII and DII holding in Kilitch Drugs (India) Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Kilitch Drugs (India) Ltd. shares.
What sector does Kilitch Drugs (India) Ltd. belong to?
Kilitch Drugs (India) Ltd. operates in the Healthcare sector.
What is the beta of Kilitch Drugs (India) Ltd. stock?
The beta of Kilitch Drugs (India) Ltd. stock is 0.99, indicating its volatility relative to the broader market.
